Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Increases By 21.4%

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 1,700 shares, a growth of 21.4% from the November 30th total of 1,400 shares. Based on an average daily trading volume, of 7,300 shares, the short-interest ratio is presently 0.2 days.

BioSyent Stock Performance

Shares of BioSyent stock traded up $0.58 on Monday, hitting $7.96. 2,335 shares of the company traded hands, compared to its average volume of 2,328. BioSyent has a 12-month low of $5.93 and a 12-month high of $8.90. The firm’s 50-day simple moving average is $8.05 and its 200 day simple moving average is $7.77.

BioSyent Cuts Dividend

The company also recently disclosed a dividend, which was paid on Monday, December 16th. Stockholders of record on Monday, December 2nd were issued a $0.0322 dividend. This represents a dividend yield of 1.6%. The ex-dividend date was Friday, November 29th.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.